HAW: Neurological Stereotaxic Instrument
What it covers
A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.
The identification in 21 CFR 882.4560, stereotaxic instrument. FDA gives HAW no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262214 | Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S) | Guangzhou Aimooe Technology Co., Ltd. | Oct 15, 2026 | Traditional |
| K253856 | Geniant Cranial (Navigated Neurosurgical Positioning Robot) | Koh Young Technology, Inc. | Sep 10, 2026 | Traditional |
| K261932 | Leksell® Vantage Stereotactic System | Elekta Solutions AB | Aug 5, 2026 | Traditional |
| K253663 | Zeta Navigation System | Zeta Surgical, Inc. | May 1, 2026 | Traditional |
| K253379 | Stealth AXiS Cranial clinical application | Medtronic Navigation, Inc. | Mar 26, 2026 | Traditional |
| K231897 | NeuroAlign software | Medivis, Inc. | Oct 21, 2025 | Traditional |
| K251317 | SOLOPASS 2.0 System | Intravent Medical Partners | Sep 5, 2025 | Traditional |
| K250893 | Ball Joint Guide Array (66295) | Bayer Medical Care, Inc. | Sep 4, 2025 | Traditional |
| K250505 | EZ-FIDUCIALS | Phasor Health, LLC | Jul 9, 2025 | Traditional |
| K242575 | Stereotaxic Guiding Surgical Devices, NaoTrac S | Brain Navi Biotechnology Co., Ltd. | May 23, 2025 | Traditional |
Clearances by year
118 HAW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 5 | 162 |
| 2025 | 9 | 163 |
| 2024 | 7 | 107 |
| 2023 | 14 | 142 |
| 2022 | 7 | 128 |
| 2021 | 9 | 168 |
| 2020 | 5 | 88 |
| 2019 | 10 | 147 |
| 2018 | 6 | 112 |
| 2017 | 7 | 226 |
| 2016 | 9 | 175 |
| 2015 | 10 | 232 |
| 2014 | 5 | 238 |
| 2013 | 3 | 172 |
| 2012 | 8 | 178 |
| 2011 | 4 | 66 |
Who submits
57 applicants cleared a HAW device since 2011. 50% of the clearances went to applicants in United States, then Germany (20%), Canada (8%) and France (8%). By type: Traditional 83%, Special 16% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| Medtronic Navigation, Inc. | 15 |
| Brainlab AG | 12 |
| ClearPoint Neuro, Inc. | 10 |
| Medtech S.A | 4 |
| Mri Interventions, Inc. | 4 |
| Synaptive Medical, Inc. | 4 |
| 7D Surgical, Inc. | 3 |
| Elekta Instrument AB | 3 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 882.4560.
Standards
21 CFR 882.4560 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HAW clearances declared.
Ask about HAW
Questions about HAW
What is FDA product code HAW?
Product code HAW, “Neurological Stereotaxic Instrument” in FDA's classification database, is a Class II device type under 21 CFR 882.4560 (stereotaxic instrument), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 426 clearances under HAW, 118 of them since 2011.
How many 510(k) clearances are there under HAW?
FDA’s 510(k) database listed 426 clearances under HAW as of Oct 29, 2026, 118 of them decided since 2011; the most recent decision was Oct 15, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a HAW 510(k)?
For the 15 HAW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 162 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most HAW clearances?
Since 2011: Medtronic Navigation, Inc. (15), Brainlab AG (12), ClearPoint Neuro, Inc. (10), Medtech S.A (4) and Mri Interventions, Inc. (4). 57 applicants have cleared a HAW device in that time.